thyrotropin-releasing hormone | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | TRH | ||||||
NCBI gene | 7200 | ||||||
HGNC | 12298 | ||||||
OMIM | 275120 | ||||||
RefSeq | NM_007117 | ||||||
UniProt | P20396 | ||||||
Other data | |||||||
Locus | Chr. 3 q13.3-q21 | ||||||
|
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.041.934 |
Chemical and physical data | |
Formula | C16H22N6O4 |
Molar mass | 362.390 g·mol−1 |
3D model (JSmol) | |
| |
|
Thyrotropin-releasing hormone (TRH) is a hypophysiotropic hormone produced by neurons in the hypothalamus that stimulates the release of thyroid-stimulating hormone (TSH) and prolactin from the anterior pituitary.
TRH has been used clinically for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans.[1] Its pharmaceutical form is called protirelin (INN) (/proʊˈtaɪrɪlɪn/).